What is it about?
In their Commentary, Raynor and Giordano make misleading statements that ignore evidence and content of the case report. They refer to the therapy as a case study, misrepresenting the fact that it clearly describes a husband’s attempt to save the life of his 81-year-old wife. She was admitted to hospice on April 8, 2015, with advanced Alzheimer dementia (AD), with a life expectancy of less than 6 months. Following the computed tomography (CT) scan treatments, starting on July 23, 2015, the patient recovered sufficiently to be discharged from hospice on November 20, 2015, as determined by her caregivers and as evaluated by her clinical neuropsychology specialist.
Featured Image
Why is it important?
Alzheimer dementia (AD) is a very serious disease that has an enormous impact on patients and the social medicare system. There is no cure or disease-modifying therapy currently available, and AD inevitably progresses in all patients. The discovery that low doses of ionizing radiation can reverse AD symptoms and may be used to defer AD progression, in early-stage patients, means they could remain in their homes instead of being transferred to a long-term care facility. The case report http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826954/ recommended proper clinical studies to confirm the discovery. The Commentary criticized the case report and diminished its significance.
Perspectives
The response to the criticisms in the Commentary pointed out its errors and omissions. It rebutted the criticisms and exposed the misleading statements. It briefly described the history of the case of AD and how it led to the discovery of the efficacy CT scans in treating neurodegenerative diseases. It referenced the Update letter https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347268/ that described the patient's ongoing booster treatments and successful treatment of a Parkinson's disease patient with CT scans. Proper clinical studies are urgently needed.
Dr. Jerry M Cuttler
Cuttler & Associates
Read the Original
This page is a summary of: Response to Commentary: Treating Alzheimer Dementia With CT-Induced Low-Dose Ionizing Radiation: Problematic, Yet Potential for More Precise Inquiry, Dose-Response, July 2017, SAGE Publications,
DOI: 10.1177/1559325817729248.
You can read the full text:
Contributors
The following have contributed to this page
